Hyperbaric oxygen therapy for diabetes-related foot ulcers: a review of reviews
HAYES, Inc
Record ID 32018000103
English
Authors' recommendations:
Rationale:
Diabetes mellitus can damage blood vessels, compromising blood flow and oxygen circulation. Resulting tissue hypoxia may contribute to failure of wounds to heal. Hyperbaric oxygen therapy (HBOT) has been proposed as a treatment adjunct to wound care to improve oxygenation and promote healing when a diabetic patient has chronic foot ulcers despite standard wound therapy alone.
Technology Description:
HBOT is administered when patients enter and remain in a compression chamber that delivers pressurized pure oxygen, thus breathing the pressurized oxygen. In the hyperbaric chamber, the elevated concentration and pressure of the oxygen increase the amount of oxygen dissolved in the patient's blood. Pressure at sea level is 1 atmosphere absolute (ATA). In clinical research on diabetes-related chronic foot ulcers, HBOT is typically delivered at 2.2 to 2.5 ATA for 60 to 120 minutes per session, with 20 to 40 sessions given either
daily or twice daily for 5 or 6 days per week. These treatment sessions most typically occur in 90-minute sessions 5 times per week.
Controversy:
HBOT is a time-intensive and costly treatment with safety risks and questionable clinical efficacy.
Key Questions:
For the adjunctive treatment of chronic foot ulcers in adults with diabetes mellitus: What is the efficacy of HBOT in terms of improved wound healing and reduction in the incidence of amputation? What complications are associated with HBOT? Have definitive patient selection criteria been established for HBOT for diabetes-associated foot ulcers?
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
The report may be purchased from:
http://www.hayesinc.com/hayes/crd/?crd=73466
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Diabetic Foot
- Foot Ulcer
- Humans
- Hyperbaric Oxygenation
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.